Alerts8.8.24
HHS-OIG Draws Legal Boundaries for Patient Caregiver Support Provided by Biotech Company

The HHS-OIG released a favorable opinion regarding a biotechnology company providing travel support and an unfavorable opinion regarding the company providing fertility services support
The U.S. Department of Health and Human Services’ Office of Inspector General (HHS-OIG) recently released Advisory Opinion No. 24-05, a favorable opinion regarding the federal Anti-Kickback Statute (AKS) and civil monetary penalty laws against beneficiary inducements (CMP) as applied to travel, lodging, meals, and other travel expense assistance to patients and caregivers provided by a biotechnology company, and an unfavorable opinion regarding the company’s provisions of fertility preservation services.
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
